Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (651-660 of 751) with videos related to

Pageof 76
Sort By:
European Heart Journal|October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn H Alexander, Renato D Lopes, Laine Thomas, et al.
American Heart Journal|June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationSaibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation. Heart Failure|April 12, 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn J V McMurray, Justin A Ezekowitz, Basil S Lewis, et al.
BMC Medical Genetics|April 24, 2008
Genetic and functional association of FAM5C with myocardial infarctionJessica J Connelly, Svati H Shah, Jennifer F Doss, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
American Heart Journal|September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Journal of the American Heart Association|June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart DiseaseLars Wallentin, Claes Held, Paul W Armstrong, et al.
Journal of the American Heart Association|December 10, 2024
Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HFSatoshi Shoji, Lisa Kaltenbach, Bradi B Granger, et al.
Journal of Cardiac Failure|July 29, 2022
The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HFVishal N Rao, Lisa A Kaltenbach, Bradi B Granger, et al.
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Pageof 76

Showing results (651-660 of 751) with videos related to

Sort By:
Pageof 76
European Heart Journal|October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn H Alexander, Renato D Lopes, Laine Thomas, et al.
American Heart Journal|June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationSaibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation. Heart Failure|April 12, 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn J V McMurray, Justin A Ezekowitz, Basil S Lewis, et al.
BMC Medical Genetics|April 24, 2008
Genetic and functional association of FAM5C with myocardial infarctionJessica J Connelly, Svati H Shah, Jennifer F Doss, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
American Heart Journal|September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Journal of the American Heart Association|June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart DiseaseLars Wallentin, Claes Held, Paul W Armstrong, et al.
Journal of the American Heart Association|December 10, 2024
Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HFSatoshi Shoji, Lisa Kaltenbach, Bradi B Granger, et al.
Journal of Cardiac Failure|July 29, 2022
The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HFVishal N Rao, Lisa A Kaltenbach, Bradi B Granger, et al.
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Pageof 76